Citation
Wu, Diana A., et al. "Barriers to Living Donor Kidney Transplantation in the United Kingdom: a National Observational Study." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 32, no. 5, 2017, pp. 890-900.
Wu DA, Robb ML, Watson CJE, et al. Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrol Dial Transplant. 2017;32(5):890-900.
Wu, D. A., Robb, M. L., Watson, C. J. E., Forsythe, J. L. R., Tomson, C. R. V., Cairns, J., Roderick, P., Johnson, R. J., Ravanan, R., Fogarty, D., Bradley, C., Gibbons, A., Metcalfe, W., Draper, H., Bradley, A. J., & Oniscu, G. C. (2017). Barriers to living donor kidney transplantation in the United Kingdom: a national observational study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, 32(5), 890-900. https://doi.org/10.1093/ndt/gfx036
Wu DA, et al. Barriers to Living Donor Kidney Transplantation in the United Kingdom: a National Observational Study. Nephrol Dial Transplant. 2017 May 1;32(5):890-900. PubMed PMID: 28379431.
TY - JOUR
T1 - Barriers to living donor kidney transplantation in the United Kingdom: a national observational study.
AU - Wu,Diana A,
AU - Robb,Matthew L,
AU - Watson,Christopher J E,
AU - Forsythe,John L R,
AU - Tomson,Charles R V,
AU - Cairns,John,
AU - Roderick,Paul,
AU - Johnson,Rachel J,
AU - Ravanan,Rommel,
AU - Fogarty,Damian,
AU - Bradley,Clare,
AU - Gibbons,Andrea,
AU - Metcalfe,Wendy,
AU - Draper,Heather,
AU - Bradley,Andrew J,
AU - Oniscu,Gabriel C,
PY - 2016/11/07/received
PY - 2017/02/09/accepted
PY - 2017/4/6/pubmed
PY - 2018/1/5/medline
PY - 2017/4/6/entrez
KW - inequity
KW - kidney transplantation
KW - living donor
KW - pre-emptive transplantation
KW - sociodemographic disparities
SP - 890
EP - 900
JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
JO - Nephrol Dial Transplant
VL - 32
IS - 5
N2 - BACKGROUND: Living donor kidney transplantation (LDKT) provides more timely access to transplantation and better clinical outcomes than deceased donor kidney transplantation (DDKT). This study investigated disparities in the utilization of LDKT in the UK. METHODS: A total of 2055 adults undergoing kidney transplantation between November 2011 and March 2013 were prospectively recruited from all 23 UK transplant centres as part of the Access to Transplantation and Transplant Outcome Measures (ATTOM) study. Recipient variables independently associated with receipt of LDKT versus DDKT were identified. RESULTS: Of the 2055 patients, 807 (39.3%) received LDKT and 1248 (60.7%) received DDKT. Multivariable modelling demonstrated a significant reduction in the likelihood of LDKT for older age {odds ratio [OR] 0.11 [95% confidence interval (CI) 0.08-0.17], P < 0.0001 for 65-75 years versus 18-34 years}; Asian ethnicity [OR 0.55 (95% CI 0.39-0.77), P = 0.0006 versus White]; Black ethnicity [OR 0.64 (95% CI 0.42-0.99), P = 0.047 versus White]; divorced, separated or widowed [OR 0.63 (95% CI 0.46-0.88), P = 0.030 versus married]; no qualifications [OR 0.55 (95% CI 0.42-0.74), P < 0.0001 versus higher education qualifications]; no car ownership [OR 0.51 (95% CI 0.37-0.72), P = 0.0001] and no home ownership [OR 0.65 (95% CI 0.85-0.79), P = 0.002]. The odds of LDKT varied significantly between countries in the UK. CONCLUSIONS: Among patients undergoing kidney transplantation in the UK, there are significant age, ethnic, socio-economic and geographic disparities in the utilization of LDKT. Further work is needed to explore the potential for targeted interventions to improve equity in living donor transplantation.
SN - 1460-2385
UR - https://www.unboundmedicine.com/medline/citation/28379431/Barriers_to_living_donor_kidney_transplantation_in_the_United_Kingdom:_a_national_observational_study_
L2 - https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/gfx036
DB - PRIME
DP - Unbound Medicine
ER -